Figure 1

(A) Mean IOP ± standard deviation at 4 and 12 weeks after additional administration of ripasudil in the total eyes. A statistical comparison with the baseline was performed at each time point. (B) Percentage of IOP reduction from the baseline at 4 and 12 weeks after additional administration of ripasudil in the total eyes. A statistical comparison between 4 and 12 weeks was performed. *P < 0.05.